Rigel Pharmaceuticals (RIGL) Deferred Taxes (2026)

Rigel Pharmaceuticals (RIGL) posted quarterly Deferred Taxes of $2.6 million for Q1 2026.

Rigel Pharmaceuticals (RIGL) Deferred Taxes (2026) Analysis & Trends

Rigel Pharmaceuticals' Deferred Taxes history runs 1 years deep, the most recent figure standing at $2.6 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -137,876.64
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.66 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Rigel Pharmaceuticals 795.39 Mn 700.06 Mn 70.18 Mn 5.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.21 Mn
Mar 31, 2026 2.57 Mn